Sign inJoin waitlistJoin the waitlist

Stewart Spies

Nuclear Medicine

Credentials: ·

History

Nuclear Medicine

Research

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma
Journal of Clinical Oncology · 1999 · 441 citations
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial
Blood · 2002 · 211 citations
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
European Journal of Nuclear Medicine · 2000 · 191 citations

Steven Rosen
13 papers
WS
William Spies
13 papers · 3 as a fellow
GW
Gregory Wiseman
12 papers
Thomas Witzig
11 papers
Leo Gordon
10 papers
Daniel Silverman
6 papers
JS
John Sanders
6 papers
Peter Lichtenthal
6 papers
RS
Russell Schilder
5 papers
BL
Bryan Leigh
4 papers
Nancy Bartlett
4 papers
Rosalind Ramsey-Goldman
4 papers